Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Jiangsheng Xu,Yunhua Liu,Yujing Li,Hai Wang,Samantha Stewart,Kevin Van der Jeught,Pranay Agarwal,Yuntian Zhang,Sheng Liu,Gang Zhao,Jun Wan,Xiongbin Lu,Xiaoming He
DOI: https://doi.org/10.1038/S41565-019-0417-Y
IF: 38.3
2019-01-01
Nature Nanotechnology
Abstract:The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.
What problem does this paper attempt to address?